Showing results (11-20 of 377) with videos related to
Sort By:
Pageof 38
Cancer Journal (Sudbury, Mass.)|January 24, 2022
Checkpoint Inhibitors and Other Immune-Based Therapies in Acute Myeloid LeukemiaFadi Haddad, Amer M Zeidan, Naval DaverBlood|September 24, 2024
How I treat patients with AML using azacitidine and venetoclaxAndrew H Wei, Sun Loo, Naval DaverPharmacological Reviews|September 25, 2016
Targeting Immune Checkpoints in Hematologic MalignanciesGheath Alatrash, Naval Daver, Elizabeth A MittendorfHematology. American Society of Hematology. Education Program|December 9, 2023
Novel immunotherapies in the treatment of AML: is there hope?Marion Subklewe, Veit Bücklein, David Sallman, et al.Clinical Lymphoma, Myeloma & Leukemia|October 4, 2021
SOHO State of the Art Updates and Next Questions:Harnessing Apoptosis in AMLKapil Saxena, Courtney DiNardo, Naval Daver, et al.Expert Review of Hematology|February 25, 2016
Acute myeloid leukemia: advancing clinical trials and promising therapeuticsNaval Daver, Jorge Cortes, Hagop Kantarjian, et al.Clinical Lymphoma, Myeloma & Leukemia|September 1, 2020
Harnessing Apoptosis in AMLKapil Saxena, Courtney DiNardo, Naval Daver, et al.Expert Review of Hematology|August 12, 2017
Immunotherapy based approaches in myelofibrosisLucia Masarova, Srdan Verstovsek, Hagop Kantarjian, et al.Current Opinion in Hematology|December 6, 2017
Immune therapies in acute myeloid leukemia: a focus on monoclonal antibodies and immune checkpoint inhibitorsRita Assi, Hagop Kantarjian, Farhad Ravandi, et al.Critical Reviews in Oncology/Hematology|July 13, 2016
Second line therapies in polycythemia vera: What is the optimal strategy after hydroxyurea failure?Aziz Nazha, Joseph D Khoury, Srdan Verstovsek, et al.Pageof 38